228 related articles for article (PubMed ID: 2112150)
21. Potential benefit of GnRH-agonist treatment before uterine artery embolization for large fibroids: MRI prediction of fibroid volume reduction.
Lee WJ; Kim MD; Han K; Won YR; Alqahtani A; Moon S; An H
Acta Radiol; 2022 Oct; 63(10):1425-1432. PubMed ID: 34565214
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
[TBL] [Abstract][Full Text] [Related]
23. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
van de Ven J; Sprong M; Donker GH; Thijssen JH; Mak-Kregar S; Blankenstein MA
Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
[TBL] [Abstract][Full Text] [Related]
24. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630).
Lumsden MA; West CP; Hawkins RA; Bramley TA; Rumgay L; Baird DT
J Endocrinol; 1989 May; 121(2):389-96. PubMed ID: 2526844
[TBL] [Abstract][Full Text] [Related]
25. Estrogenic modulation of the gonadotropin-releasing hormone-stimulated secretory activity of the gonadotrope and lactotrope in prepubertal females with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1991 Dec; 73(6):1202-9. PubMed ID: 1955502
[TBL] [Abstract][Full Text] [Related]
26. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
Morris EP; Rymer J; Robinson J; Fogelman I
Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
[TBL] [Abstract][Full Text] [Related]
28. Medical management of fibroids.
Sankaran S; Manyonda IT
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
[TBL] [Abstract][Full Text] [Related]
29. The influences of GnRH, oxytocin and vasoactive intestinal peptide on LH and PRL secretion by porcine pituitary cells in vitro.
Bogacka I; Siawrys G; Okrasa S; Kaminski T; Przala J
J Physiol Pharmacol; 2002 Sep; 53(3):439-51. PubMed ID: 12369740
[TBL] [Abstract][Full Text] [Related]
30. [GnRH analogues for the treatment of fibroids].
Murillo EO; Cano A
Med Clin (Barc); 2013 Jul; 141 Suppl 1():35-9. PubMed ID: 24314566
[TBL] [Abstract][Full Text] [Related]
31. Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue.
Wu X; Wang H; Englund K; Blanck A; Lindblom B; Sahlin L
Fertil Steril; 2002 Nov; 78(5):985-93. PubMed ID: 12413982
[TBL] [Abstract][Full Text] [Related]
32. Direct inhibitory effect of gonadotropin-releasing hormone upon luteal luteinizing hormone receptor and steroidogenesis in hypophysectomized rats.
Jones PB; Hsueh AJ
Endocrinology; 1980 Dec; 107(6):1930-6. PubMed ID: 6253282
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate.
Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Inoue M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5405-11. PubMed ID: 11701714
[TBL] [Abstract][Full Text] [Related]
34. Decidual-type prolactin expression by the human myometrium.
Gellersen B; Bonhoff A; Hunt N; Bohnet HG
Endocrinology; 1991 Jul; 129(1):158-68. PubMed ID: 2055179
[TBL] [Abstract][Full Text] [Related]
35. Effects of prolactin on the luteinizing hormone response to gonadotropin- releasing hormone in primary pituitary cell cultures during the ovine annual reproductive cycle.
Gregory SJ; Townsend J; McNeilly AS; Tortonese DJ
Biol Reprod; 2004 May; 70(5):1299-305. PubMed ID: 14695904
[TBL] [Abstract][Full Text] [Related]
36. [GnRH-analogs in the therapy of uterine myomatosis].
Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
[TBL] [Abstract][Full Text] [Related]
37. Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor.
Parker JD; Malik M; Catherino WH
Fertil Steril; 2007 Jul; 88(1):39-46. PubMed ID: 17296196
[TBL] [Abstract][Full Text] [Related]
38. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
Kessel B; Liu J; Mortola J; Berga S; Yen SS
Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience in the treatment of fibroids with leuprolide and other GnRH agonists.
Friedman AJ
Obstet Gynecol Surv; 1989 May; 44(5):311-3. PubMed ID: 2498793
[No Abstract] [Full Text] [Related]
40. Effects of gonadotropin-releasing hormone agonist and clomiphene citrate on estrogen/progesterone-induced hyperprolactinemia in monkeys.
Groff TR; Olive DL; Riehl RM; Schenken RS
Fertil Steril; 1990 Feb; 53(2):346-50. PubMed ID: 2105248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
